Eight functions. 100 ranked questions.
Every team that touches the pipeline asks different questions of the same registry rows. Pick yours.
R&D / Discovery
Decide where to point a programme before you commit budget: how crowded an indication is, what has already failed, and which mechanisms the field is converging on.
Top question: Indication prioritization
15 use casesBusiness Development & Licensing
Time the conversation before the readout. See which assets approach Phase 2/3 completion, where whitespace sits, and what a target really has in its pipeline.
Top question: Deal timing intelligence
14 use casesMarket Access & HEOR
Build the evidence base payers and HTA bodies will reference: endpoints, comparators, outcome sets and where trials concentrate.
Top question: Endpoint benchmarking
12 use casesMarketing & Sales
See launches coming, size markets on real activity, and focus field teams where the clinical activity is.
Top question: Approved-product & label landscape
11 use casesRegulatory Affairs
Ground submissions in precedent: designs, endpoints, populations and designations regulators have already accepted.
Top question: Regulatory intelligence monitoring
11 use casesMedical Affairs
Map evidence gaps, prepare congresses and prioritise investigator-sponsored studies with the whole field in view.
Top question: Evidence gap mapping
11 use casesPharmacovigilance & Drug Safety
Put a safety signal in context across the class: who is running what, which populations are enrolled, and which trials stopped.
Top question: Signal detection context
10 use casesClinical Operations
Plan feasibility, site selection and timelines against the trials competing for the same patients.
Top question: Feasibility assessment